An Overview of Potential Treatment Adverse Effects
An expert on chronic lymphocytic leukemia discusses adverse effects encountered by patients who are receiving BTK inhibitors or venetoclax-based regimens.
EP: 1.Understanding a CLL Diagnosis
EP: 2.Diagnostic Tests in CLL
EP: 3.Goals of Treatment for Patients With CLL
EP: 4.Current First-Line Treatment Options in CLL
EP: 5.Factors That Guide CLL Treatment Decisions
EP: 6.What to Expect from Treatment
EP: 7.Overview of Efficacy and Safety Data for Current CLL Treatment Options
EP: 8.Acalabrutinib-Based Treatment Clinical Trial Updates
EP: 9.Venetoclax-Based Treatment Clinical Trial Updates
EP: 10.Zanubrutinib-Based Treatment Clinical Trial Updates
EP: 11.Ibrutinib-Based Treatment Clinical Trial Updates
EP: 12.Newer Combinations for the Treatment of CLL
EP: 13.What to Know Before Starting Your CLL Treatment
Now Viewing
EP: 14.An Overview of Potential Treatment Adverse Effects
EP: 15.Treatment Decisions in R/R CLL
EP: 16.Shared Decision-Making and Supportive Care in the CLL Treatment Journey
EP: 17.Optimizing Overall Health During CLL Management
EP: 18.Getting the Most From Your CLL Care Team
Video content above is prompted by the following question(s):
- What types of adverse effects may patients encounter with BTK inhibitor therapy? Venetoclax?
- How are these adverse effects typically managed and how does a multidisciplinary team contribute to this process?
- What guidance do you offer to patients to assist them in effective management of potential adverse events?
Recent Videos
Related Content
